NTRA News and Press, Natera Inc. From 03/09/22

Update 10:53am: Adds analyst comment, updates shares. Natera Inc. (NASDAQ:NTRA) dropped 30% after Hindenburg Research released a new short report on the prenatal testing company. Hindenburg alleges that Natera's revenue growth has been "fueled by deceptive sales and billing practice...

Gainers: Sunshine Biopharma (NASDAQ:SBFM) +159%. Cano Health (NYSE:CANO) +34%. Celyad Oncology (NASDAQ:CYAD) +24%. Mainz Biomed (NASDAQ:MYNZ) +21%. Bright Health Group (NYSE:BHG) +17%. Losers: Ontrak (NASDAQ:OTRK) -20%. Invacare (NYSE:IVC) -19%. Na...

Yext (NYSE:YEXT) -32% on Q4 results. Cricut (NASDAQ:CRCT) -30% on Q4 results. Stitch Fix (NASDAQ:SFIX) -22% on Q2 results. Ontrak (NASDAQ:OTRK) -22% on Q4 results. Nine Energy Service (NYSE:NINE) -17%. Hycroft Mining (NASDAQ:HYMC) -16%. PolyMet Mining (...

Natera Inc. (NASDAQ:NTRA) dropped 15% in premarket trading after Hindenburg Research released a new short report on the prenatal testing company Hindenburg alleges that Natera's revenue growth has been "fueled by deceptive sales and billing practices." The short report notes the com...

Natera, Inc. (NTRA) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Solomon Moshkevich - General Manager of Oncology & Transplant Conference Call Participants Tejas Savant -...

The following slide deck was published by Natera, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Natera, Inc. 2021 Q4 - Results - Earnings Call Presentation

Natera press release (NASDAQ:NTRA): Q4 GAAP EPS of -$1.48 misses by $0.18. Revenue of $173M (+53.9% Y/Y) beats by $4.19M. Outlook: Natera anticipates 2022 total revenue of $770 million to $790 million. Q1 Consensus Revenue Estimate $172.85M; 2022 Consensus Revenue Estimate $761.54M. 2022...

Natera Reports Fourth Quarter and Full Year 2021 Financial Results PR Newswire AUSTIN, Texas , Feb. 24, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the fourth quarter and ye...

Natera Announces Fourth Quarter and Fiscal 2021 Earnings Conference Call PR Newswire AUSTIN, Texas , Feb. 17, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for ...

Natera Announces Results of Large, Multi-Center Clinical Experience Study Showing Excellent Positive Predictive Value of the Prospera™ Kidney Test PR Newswire AUSTIN, Texas , Feb. 17, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in...